The Effects of High Intensity Exercise on Cardiovascular Function in Men with Metastatic Castrate-Resistant Prostate Cancer (MCRPC): a sub study of GAP4-QLD INTense Exercise foR surVivAL among men with MCRPC (INTERVAL - MCRPC)
- Conditions
- Metastatic Castrate-Resistant Prostate Cancer (MCRPC)Cancer - Prostate
- Registration Number
- ACTRN12617000847314
- Lead Sponsor
- niversity of Queensland
- Brief Summary
il as of yet.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 5
As participants for the sub-study will be recruited through the GAP4 INTERVAL clinical trial (Trial ID: NCT02730338), the key inclusion criteria have been listed previously in INTense Exercise foR surVivAL Among Men With Metastatic Castrate-Resistant Prostate Cancer (INTERVAL) (Trial ID: NCT02730338).
No additional key inclusion criteria are required to be met for involvement in this sub-study.
As participants for the sub-study will be recruited through the GAP4 INTERVAL clinical trial (Trial ID: NCT02730338), the key exclusion criteria have been listed previously in INTense Exercise foR surVivAL Among Men With Metastatic Castrate-Resistant Prostate Cancer (INTERVAL) (Trial ID: NCT02730338).
No additional key exclusion criteria are required to be met for involvement in this sub-study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method